BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $393 | -27.4% | 10,412 | -12.3% | 0.01% | -30.0% |
Q2 2023 | $541 | +12.2% | 11,875 | 0.0% | 0.02% | +11.1% |
Q1 2023 | $482 | -63.9% | 11,875 | -54.6% | 0.02% | -63.3% |
Q4 2022 | $1,334 | -99.8% | 26,181 | +120.7% | 0.05% | +104.2% |
Q3 2022 | $639,000 | -37.7% | 11,861 | -25.8% | 0.02% | -36.8% |
Q2 2022 | $1,026,000 | +8.5% | 15,975 | +30.9% | 0.04% | +18.8% |
Q1 2022 | $946,000 | +35.0% | 12,206 | +49.4% | 0.03% | +28.0% |
Q4 2021 | $701,000 | -9.5% | 8,171 | -15.2% | 0.02% | -10.7% |
Q3 2021 | $775,000 | -73.2% | 9,638 | -73.2% | 0.03% | -71.4% |
Q2 2021 | $2,895,000 | -8.1% | 35,957 | -3.8% | 0.10% | -16.9% |
Q1 2021 | $3,151,000 | -42.6% | 37,366 | -45.4% | 0.12% | -48.5% |
Q4 2020 | $5,494,000 | -18.3% | 68,468 | -18.1% | 0.23% | -26.4% |
Q3 2020 | $6,726,000 | -7.7% | 83,642 | -1.2% | 0.31% | -17.5% |
Q2 2020 | $7,287,000 | +3.4% | 84,639 | -2.5% | 0.38% | -5.0% |
Q1 2020 | $7,047,000 | +4.0% | 86,791 | +7.2% | 0.40% | +24.8% |
Q4 2019 | $6,773,000 | – | 80,998 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |